Deciding where AI adds value in your research

Not every research problem needs machine learning. Use this decision guide to find opportunities where AI gives a clear advantage and where risks remain manageable.

Quick decision criteria

• Repetition and scale: Are you repeating the same labeling, measurement, or QC task at scale? AI helps reduce repetitive manual work and measurement variability.
• Pattern complexity: Are the signals too complex for simple rules but present in the data? AI may find subtle patterns humans miss.
• Actionability: Will the model output change a decision or process? If not, AI may only provide curiosity-level insight rather than operational value.
• Data sufficiency: Do you have representative, well-labeled data or a realistic plan to collect it? Poor data undermines model value.
• Risk & consequence: Could errors harm people, violate privacy, or lead to costly mistakes? High-risk use requires stronger validation, explainability, and governance.

Prioritizing first uses (examples)

• Low-risk, high-return (good early wins): Image-based QC to flag out-of-spec samples for human review; literature search assistants that summarize papers for a lab meeting.
• Medium risk: Predicting experimental yield to prioritize runs (human-in-the-loop decisions); automated data cleaning pipelines that change processed results.
• High risk (guarded approach): Clinical decision support, automated diagnosis, or systems that act without human oversight—require regulatory review, external validation, and explicit monitoring plans.

Quick red flags

1. Training data is biased or not representative of populations where the model will be used.
2. Model decisions are opaque and the downstream process cannot tolerate unexplained errors.
3. There is no plan for versioning, drift monitoring, or rollback in deployment.

Recommended first step

Run the risk assessment to set required validation steps, then complete the validation checklist. These two actions convert vague worry into concrete tests and documentation you can later present to collaborators, reviewers, or an ethics board.